Low triiodothyronine: A new facet of inflammation in end-stage renal disease

Journal of the American Society of Nephrology

Volumn 16, Issue 9, 2005, Pages 2789-2795

  Zoccali, Carmine ^a,b   Tripepi, Giovanni ^a   Cutrupi, Sebastiano ^a   Pizzini, Patrizia ^a   Mallamaci, Francesca ^a  

^a OSPEDALI RIUNITI   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIOTHYRONINE; THYROID HORMONE; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INFECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TRIIODOTHYRONINE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33644807502     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005040356     Document Type: Article

References (32)

1. Lim VS: Thyroid function in patients with chronic renal failure. Am J Kidney Dis 38[Suppl 1]: S80-S84, 2001
2. De Groot LJ: Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J Clin Endocrinol Metab 84: 151-164, 1999
3. Lo JC, Chertow GM, Go AS, Hsu CY: Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67: 1047-1052, 2005
4. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donate L: Low-T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 107: 708-713, 2003
5. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12: 1549-1557, 2001
6. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B: Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int Suppl 80: 103-108, 2002
7. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
8. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
9. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM: Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 55: 1945-1951, 1999
10. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P: Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17: 1684-1688, 2002
11. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16[Suppl 1]: S83-S88, 2005
12. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS: Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 18: 1207-1213, 2000
13. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD: Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80: 299-307, 2004
14. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E: Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 17: 269-274, 1994
15. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM: Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77: 1695-1699, 1993
16. van der PT, Romijn JA, Wiersinga WM, Sauerwein HP: Tumor necrosis factor: A putative mediator of the sick eu thyroid syndrome in man. J Clin Endocrinol Metab 71: 1567-1572, 1990
17. Stouthard JM, van der PT, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, Romijn JA: Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79: 1342-1346, 1994
18. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM: Induced illness in interleukin-6 (IL-6) knock-out mice: A causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology 137: 5250-5254, 1996
19. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM: Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab 80: 971-976, 1995
20. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 15: 1624-1630, 2000
21. Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, Massry SG: The thyroid in end-stage renal disease. Medicine (Baltimore) 67: 187-197, 1988
22. Kaptein EM: Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17: 45-63, 1996
23. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Muller B: Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166: 379-386, 2003
24. Chadarevian R, Bruckert E, Giral P, Turpin G: Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 10: 481-486, 1999
25. Deng MC, Erren M, Lutgen A, Zimmermann P, Brisse B, Schmitz W, Assmann G, Breithardt G, Scheid HH: Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure. Int J Cardiol 57: 129-134, 1996
26. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A: Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81: 443-447, 1998
27. Hamilton MA, Stevenson LW: Thyroid hormone abnormalities in heart failure: Possibilities for therapy. Thyroid 6: 527-529, 1996
28. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772, 2000
29. Bruckert E, Giral P, Chadarevian R, Turpin G: Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. J Cardiovasc Risk 6: 327-331, 1999
30. Klein I: Thyroid hormone and the cardiovascular system. Am J Med 88: 631-637, 1990
31. Kaysen GA, Kumar V: Inflammation in ESRD: Causes and potential consequences. J Ren Nutr 13: 158-160, 2003
32. Bommer C, Werle E, Walter-Sack I, Keller C, Gehlen E, Wanner C, Nauck M, Marz W, Wieland H, Bommer J: D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients. J Am Soc Nephrol 9: 90-96, 1998